Ignyta, Lieden University team on RA biomarker research

Ignyta will work with Leiden University Medical Center on new biomarker research involving patients with early synovitis and rheumatoid arthritis. The goal of the work is to develop a diagnostic test for patients with early-stage rheumatoid arthritis, and so the joint effort will focus on assessing epigenetic biomarker signatures for both conditions. Such a diagnostic, ideally, will be designed with both high specificity and high sensitivity. Ignyta launched two years ago and is based in San Diego. Release

BD&L Summit

Deal-Making Insights for the Life Sciences Industry

Bringing together key deal-makers and serving as an open forum for cross-functional business development and legal teams to share valuable insights and actionable strategies on successfully managing alliances, licensing agreements, and M&A deals.